World-class scientific capability, a digital presence to match
We developed a digital platform that presents Axolabs’ leadership in RNA therapeutics clearly and confidently, designed to serve both investors evaluating the opportunity and partners assessing capability.
The Results:
- 01
A digital adaptation of the Ward.Studio brand
- 02
An investor and partner-facing platform
- 03
A mobile-first digital experience
Chapter 01
The brand, by Ward.Studio
Craig Ward and Ward.Studio created a striking brand identity for Axolabs that captures the precision and innovation of RNA therapeutics. The logo, colour palette, and visual language they developed gave us a strong foundation to build the digital platform on. Working with the designer, we adapted the brand for digital and applied it across the platform.
Chapter 02
Digital platform, by Copia
Using Ward.Studio’s brand as the foundation, we designed and built the Axolabs digital platform, translating the visual identity into a structured, functional investor and partner-facing website that communicates the science, the commercial opportunity, and the team behind it.
